ALIM Alimera Sciences Net earnings per share (EPS TTM)

Graphic logo of Alimera Sciences Inc (ALIM)

Insurance payout limits are constraining the pricing power of Alimera Sciences (ALIM), yet the 12-month net income per share trend demonstrates business adaptability, with the metric currently standing at -0.31. Stability is underpinned by a European CMO partner and US-based warehouses. Sales growth for Yutiq and Iluvien, coupled with the prospect of an acquisition by a tech giant, offset the risks and confirm the company's fundamental strength.

ALIM Alimera Net earnings per share for the last four quarters (07/04/2022 - 09/21/2024)

Alimera - analytical breakdowns and key metrics (ALIM)

- share price and expert price forecast:
Stock Quotes Alimera|ALIM - Average Forecast Price
- market capitalization data:
Market Capitalization Alimera Sciences, Inc.|ALIM - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Alimera Sciences|ALIM - Book Valuation of Business|Market Capitalization to Book Value Ratio alimerasciences.com|ALIM - Company Total Assets
- debt and liquidity details:
Debt to Equity Alimera Sciences|ALIM - Long-Term Debt to Equity|Short-Term Debt to Capital Alimera Sciences Inc|ALIM - Company Total Debt Obligations|Debt to Book Capitalization Ratio ALIM|ALIM - Company Long-Term Liabilities|Company Short-Term Debts Alimera Sciences|Quick Liquidity alimerasciences.com
- earnings and multiples data:
ALIM - Final Profit|Projected Future Earnings Alimera Sciences|ALIM - P/E Multiple|Projected Price to Earnings Alimera Sciences, Inc.|ALIM - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alimera Sciences|ALIM - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Alimera Sciences|ALIM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth alimerasciences.com|ALIM - Expected net earnings per share growth this year|Earnings growth forecast for next year Alimera Sciences
- total revenue and sales volume data:
ALIM - Company Total Revenue|Company Projected Revenue Alimera Sciences Inc|ALIM - Market Cap to Revenue Ratio|Forward P/S Multiple ALIM
Fundamental company analysis:ALIM - Alimera
Mass-produced product of Alimera Sciences Inc

Integration costs following the deal with ANI Pharmaceuticals and regulatory pressure on the drug Iluvien are placing significant pressure on the margins of Alimera Sciences (ALIM). The eps_ttm_co metric measures actual earnings per share over the year, excluding the volatility of one-time write-offs. By analyzing the trend of annual net income per share, an investor can see the adjusted efficiency of the business. The current value of -0.31 reflects the actual yield of the asset. The dynamics of this indicator determine the stability of the company's market capitalization.

Competitor analysis

Alcon Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Bausch + Lomb|GKOS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Apellis Corp (APLS)|Earnings per share for the last twelve months Belite Bio|ocutx.com (OCUL) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HROW|Earnings per share for the last twelve months VRDN (Viridian Therapeutics, Inc.)|Net earnings per share (EPS TTM) LENZ (lenz-tx.com)|Net earnings per share (EPS TTM) oculis.com OCS|EyePoint Pharmaceuticals Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Kodiak Sciences Inc. KOD|ALDX: Net earnings per share (EPS TTM)|KALA BIO, Inc. (KALA) - Net earnings per share (EPS TTM)|IRD (Opus Genetics Inc) - Net earnings per share (EPS TTM)|OKYO: Earnings per share for the trailing year|Net earnings per share for the last 12 months ADVM (adverum.com)|OTLK - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CLSD (Clearside Biomedical Inc)|Earnings per share for the trailing year NBY|Kiora Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|EYEN - Net earnings per share (EPS TTM)|GHSI (Guardion Health Science) - Net earnings per share for the last 12 months|ocuphire.com - Earnings per share for the trailing year|OPT (Opthea Ltd) - Net earnings per share (EPS TTM)